Explorer les evidences

13,97 aHRAmong patients switching to dolutegravir-containing regimens, those with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 13.97 for pulmonary tuberculosis or a WHO clinical stage 4 event compared to those with preswitch viral load <200 copies/mL.

Kenyatuberculose · WHO clinical stage 4 eventpublié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 6 observations

53 %By March 2007, the estimated proportional decline in paediatric malaria admissions was 53% in Kwale.

Kenyapaludismeobservé March 2007publié 2007Malaria journaleurope_pmcdocument de 3 observations

2,32 per_100_person-yearsAmong newly enrolled adolescents and youth living with HIV (AYLHIV) in Kenya between January 2016 and December 2017, the incidence of mortality was 2.32 per 100 person-years.

KenyaVIH/sidaobservé 2016-2017publié 2023AIDS patient care and STDsPubMeddocument de 5 observations

41,99 scoreQuality of life among cancer patients in Kenya had median scores ranging from 41.99 to 53.

Kenyacancer (non précisé)PubMeddocument de 11 observations

56,6 %HITSystem 2.0 participants were more likely to receive complete PMTCT services compared to standard of care (56.6% vs. 17.1%).

KenyaVIH/sidaobservé between November 2017 and June 2019publié 2021AIDS and behaviorPubMeddocument de 2 observations

96 %Overall, service-based malaria vaccine coverage was 96% for dose 1 of RTS,S/AS01 in Kenya's pilot implementation.

Kenyapaludismeobservé 2019-2022publié 2023Malaria journaleurope_pmcdocument de 10 observations

3,18 ORComa was associated with uraemia with an odds ratio of 3.18.

Kenyauraemiapublié 2021Malaria journalPubMeddocument de 14 observations

58 %Among 2311 virally unsuppressed adolescents and young adults living with HIV in Kenya with a repeat viral load test, 1330 (58%) had confirmed treatment failure.

KenyaVIH/sidaobservé April 2017 to May 2019publié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations

27,9 %Using PCR technique, the overall malaria positivity rate was 27.9% in pregnant women and children below five years seeking healthcare services at rural health facilities in Kwale and Siaya counties in Kenya.

Kenyapaludismepublié 2021PloS onePubMeddocument de 15 observations

30 %Klebsiella pneumoniae was present in 48 (30%) of 162 HIV-attributed infant or child deaths.

KenyaVIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations

2,26 aORPatients tested in hospitals were over two times as likely to have a new HIV diagnosis as those tested in smaller facilities (i.e., health centers and dispensaries) (aOR 2.26; 95% CI = 1.60–3.21).

KenyaVIH/sidaobservé 2018publié 2022International journal of STD & AIDSPubMeddocument de 4 observations

18 %HIV prevalence among people who inject drugs in Kenya is estimated to be 18%.

KenyaVIH/sidapublié 2022Journal of substance abuse treatmentPubMeddocument de 7 observations

131 controlsA total of 131 controls were recruited in the study on ocular surface squamous neoplasia (OSSN) in Kenya.

Kenyaocular surface squamous neoplasia (OSSN)publié 2016Tropical medicine & international health : TM & IHeurope_pmcdocument de 10 observations

1,74 odds_ratioModerate-to-severe depressive symptom risk was significantly increased with low social support (adjusted odds ratio 1.74 [95% CI 1.56–1.95]).

Kenyadepressive symptomspublié 2022The lancet. PsychiatryPubMeddocument de 9 observations

For R21/Matrix-M, higher frequencies of NANP-specific activated memory IgG B cells were detected in infants versus adults.

Kenyapaludismepublié 2026Frontiers in immunologyPubMeddocument de 5 observations

33,9 %Patients treated with injectable artesunate had a significantly increased cumulative incidence of discharge by 33.9%.

Kenyapaludismepublié 2022BMJ openPubMeddocument de 9 observations

18,2 per_100000In 2013–2015, head and neck cancer incidence was highest among SEER states at 18.2 per 100,000 among men.

KenyaHead and neck cancerobservé 2013-2015publié 2021Cancer epidemiologyeurope_pmcdocument de 7 observations

73,2 %Access to HIV/AIDS information was 73.2% in non-intervention sites at end line.

KenyaVIH/sidapublié 2020African Journal of Health SciencesOpenAlexdocument de 7 observations

3,9 %HBV prevalence was 3.9% among males and 2.8% among females.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

32 %Enterococcus species accounted for 32% of microorganisms causing catheter-associated urinary tract infection in the Kenyatta National Hospital critical care unit.

Kenyacatheter-associated urinary tract infectionobservé 2019–2020publié 2020African Journal of Health SciencesOpenAlexdocument de 17 observations

96,2 %Among 210 prediabetic adults in Kenya, 96.2% had at least one additional metabolic abnormality alongside prediabetes.

Kenyaprediabetespublié 2026Diabetes research and clinical practicePubMeddocument de 6 observations

15,7 %Parasite prevalence was 15.7% in South Central Somalia.

Kenyapaludismeobservé 2007publié 2008PloS oneeurope_pmcdocument de 5 observations

14,1 %The prevalence of cachexia among cancer out-patients in Nairobi, Kenya was 14.1%.

Kenyacancer (non précisé)publié 2017Journal of nutritional scienceeurope_pmcdocument de 10 observations

77,2 %Sexual economic exchange was reported by 403 (77.2%) sexually active women among 536 sexually active women screened in Kisumu, Kenya from January 2017 to May 2018.

KenyaVIH/sidaobservé January 2017 to May 2018publié 2025Archives of sexual behaviorPubMeddocument de 8 observations

14 casesReasons for exclusion at screening included hepatitis (n = 14).

Kenyahepatitispublié 2022BMC public healthPubMeddocument de 11 observations